Laurence A. Turka
Chief Scientific Officer, Rubius Therapeutics (United States).
Companies
- Rubius Therapeutics (United States)Chief Scientific Officer Jan 28, 2020 to Jan 31, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Rubius Therapeutics (United States)18,391 shares2Jan 31, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 31, 2023Sold 2,593 shares at $0.24 of Rubius Therapeutics (United States)2
- Jan 31, 2023Exercised options 8,625 shares of Rubius Therapeutics (United States)2
- Jan 29, 2023Exercised options 7,438 shares of Rubius Therapeutics (United States)2
- Feb 1, 2022Sold 2,517 shares at $6.57 of Rubius Therapeutics (United States)3
- Jan 29, 2022Exercised options 7,438 shares of Rubius Therapeutics (United States)3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 1, 2022